Skip to content
The Policy VaultThe Policy Vault

Adcirca tabletsCigna

Pulmonary arterial hypertension (PAH) (WHO Group I)

Preferred products

  • generic tadalafil tablets (20 mg)
  • Alyq

Initial criteria

  • Patient meets the standard Pulmonary Arterial Hypertension – Phosphodiesterase Type 5 Inhibitors Prior Authorization Policy criteria
  • Patient has tried Alyq or generic tadalafil 20 mg tablets [documentation required or verification of prescription claims history required]
  • Patient cannot continue to use generic tadalafil 20 mg tablets due to a formulation difference in the inactive ingredient(s) (e.g., dyes, fillers, preservatives) between the Brand and the bioequivalent product which, per the prescriber, would result in a significant allergy or serious adverse reaction

Approval duration

1 year